China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China flag China · Delayed Price · Currency is CNY
18.56
+0.15 (0.81%)
Apr 8, 2026, 3:00 PM CST

SHA:600062 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,9142,8513,4622,6302,834
Trading Asset Securities
500.87--200.49803.58
Cash & Short-Term Investments
2,4152,8513,4622,8313,638
Cash Growth
-15.27%-17.65%22.29%-22.18%11.51%
Accounts Receivable
2,8272,5992,6332,2111,978
Other Receivables
73.06207.781,363468.9866.14
Receivables
2,9002,8063,9972,6802,044
Inventory
1,5781,5941,6881,9001,665
Prepaid Expenses
----0.59
Other Current Assets
213.48225.84235.49227.89174.55
Total Current Assets
7,1077,4779,3827,6397,523
Property, Plant & Equipment
4,4484,2384,0463,5712,957
Long-Term Investments
1,1551,0481,016350.29303.43
Goodwill
1,077878.49907.9934.96788.19
Other Intangible Assets
1,8661,7491,7681,6481,193
Long-Term Accounts Receivable
1.562.37---
Long-Term Deferred Tax Assets
192.99135.8140.58127.1973.77
Long-Term Deferred Charges
695.98744.92813792.3723.66
Other Long-Term Assets
465.52412.4129.8103.27114.6
Total Assets
17,00916,68618,20315,16513,676
Accounts Payable
668.98835.81740.49750.39847.4
Accrued Expenses
1,6371,6731,6911,4961,283
Short-Term Debt
130.9599.0569.4736.954.75
Current Portion of Long-Term Debt
14.2512200.250.27-
Current Portion of Leases
15.1811.3122.4919.4617.84
Current Income Taxes Payable
40.5243.8465.7277.7859.62
Current Unearned Revenue
198.97174.88293.43194.21201.35
Other Current Liabilities
316.521,1531,696507.17317.31
Total Current Liabilities
3,0224,0034,7793,0822,731
Long-Term Debt
1,0371,090-200-
Long-Term Leases
14.3222.129.9532.9335.43
Long-Term Unearned Revenue
144.75160.67182.31199.61153.92
Pension & Post-Retirement Benefits
163.3169.64147.55144.18157.75
Long-Term Deferred Tax Liabilities
122.67123.6158.59176.17120.35
Other Long-Term Liabilities
5.25.675.675.061.11
Total Liabilities
4,5095,5745,3033,8403,199
Common Stock
1,0391,0391,0401,0431,043
Additional Paid-In Capital
216.27193.45837.55275.22149.39
Retained Earnings
10,4269,26910,4609,4158,718
Treasury Stock
-34.02-74.36-125.56-175.68-
Comprehensive Income & Other
-13.01-19.31.32-1.43-5.17
Total Common Equity
11,63410,40812,21310,5569,905
Minority Interest
866.18703.89685.95768.46571.06
Shareholders' Equity
12,50011,11212,89911,32510,477
Total Liabilities & Equity
17,00916,68618,20315,16513,676
Total Debt
1,2111,234322.16289.6158.02
Net Cash (Debt)
1,2041,6163,1402,5413,580
Net Cash Growth
-25.52%-48.52%23.55%-29.00%9.73%
Net Cash Per Share
1.161.573.062.453.43
Filing Date Shares Outstanding
1,0331,0271,0211,0401,043
Total Common Shares Outstanding
1,0331,0271,0211,0401,043
Working Capital
4,0853,4744,6024,5564,792
Book Value Per Share
11.2610.1311.9610.159.49
Tangible Book Value
8,6917,7809,5377,9737,925
Tangible Book Value Per Share
8.417.579.347.677.60
Buildings
3,7153,4523,1622,5792,314
Machinery
4,6904,3584,0003,3062,758
Construction In Progress
393.75455.14570.38439.72272.81
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.